+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Personality traits and escitalopram treatment outcome in major depression



Personality traits and escitalopram treatment outcome in major depression



Nordic Journal of Psychiatry 72(5): 354-360



Selective serotonin re-uptake inhibitors (SSRI) have proven to be effective in treatment of depression. Still, treatment efficacy varies significantly from patient to patient and about 40% of patients do not respond to initial treatment. Personality traits have been considered one source of variability in treatment outcome. Current study aimed at identifying specific personality traits that could be predictive of treatment response and/or the dynamics of symptom change in depressive patients. In a sample of 132 outpatients with major depressive disorder (MDD) treated with an SSRI-group antidepressant escitalopram, the Swedish universities Scales of Personality (SSP) were used in order to find predictive personality traits. For the assessment of the severity of depressive symptoms and the improvement rates, the Hamilton Depression Scale (HAM-D) and Montgomery-Åsberg Depression Rating Scale (MADRS) were used. Escitalopram-treated MDD patients with higher social desirability achieved more rapid decrease in symptom severity. None of the studied traits predicted the end result of the treatment. The findings suggest that specific personality traits may predict the trajectory of symptom change rather than the overall improvement rate.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065400415

Download citation: RISBibTeXText

PMID: 29688152

DOI: 10.1080/08039488.2018.1465590


Related references

Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. Journal of Affective Disorders 104(1-3): 119-126, 2007

Personality traits as predictors for the outcome of lithium augmentation in treatment-resistant depression. Psychiatry Research 220(3): 1144-1146, 2014

Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial. Plos one 7(2): E31980, 2012

Dimensional personality traits and treatment outcome in patients with major depressive disorder. Journal of Affective Disorders 108(3): 241-250, 2008

Personality pathology and treatment outcome in major depression: a review. American Journal of Psychiatry 159(3): 359-371, 2002

Is there any specific personality disorder or personality disorder cluster that worsens the short-term treatment outcome of major depression?. Acta Psychiatrica Scandinavica 88(5): 342-349, 1993

Association between personality traits and Escitalopram treatment efficacy in panic disorder. Nordic Journal of Psychiatry 71(6): 433-440, 2017

Cluster a personality disorder: a marker of worse treatment outcome of major depression?. Psychiatry Research 53(2): 153-159, 1994

Temperament, personality, and treatment outcome in major depression: a 6-month preliminary prospective study. Neuropsychiatric Disease and Treatment 13: 17-24, 2017

Does personality disorder co-morbidity impact treatment outcome for patients with major depression? A multi-level analysis. Journal of Personality Disorders 25(1): 1-15, 2011

Escitalopram for the treatment of major depression and anxiety disorders. Expert Review of Neurotherapeutics 8(4): 537-552, 2008

Escitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. International Journal of Neuropsychopharmacology 7(3): 283-290, 2004

Thyroid autoimmunity and treatment response to escitalopram in major depression. Nordic Journal of Psychiatry 64(4): 253-257, 2010

Personality traits are associated with acute major depression across the age spectrum. Aging and Mental Health 16(4): 472-480, 2012

Mean platelet volume in patients with major depression: effect of escitalopram treatment. Journal of Clinical Psychopharmacology 29(4): 368-371, 2009